PDF) Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by
International Manual of Oncology Practice | SpringerLink
Cancers | Free Full-Text | A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First-
PDF) An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with
PDF) Adrenal Incidentalomas in Cancer Patients Are Not Always “Innocent”: A Case Report and Review of the Literature
Table of Contents page: Journal of Thoracic Oncology
PDF) 144PCyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab
Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer - Urology
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink
PDF) Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group
PDF) Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer | Christos Alamanis and Christos Papadimitriou - Academia.edu
PDF) Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton
PDF) Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: A Hellenic Cooperative Oncology Group (HeCOG) study
Table of Contents page: Journal of Thoracic Oncology
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink
PDF) Bevacizumab in Ovarian Cancer
PDF) Mitogen-Activated Protein Kinase Activation in Lung Adenocarcinoma: A Comparative Study between Ever Smokers and Never Smokers
PDF) Current and Emerging Roles of Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small Cell Lung Cancer
Vol 4, No 14 (July 2016) - Annals of Translational Medicine
PDF) Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: The experience of the Hellenic
Table of Contents page: Journal of Thoracic Oncology
Table of Contents page: Journal of Thoracic Oncology
